Updated Jul 16, 2026
Dutia Suren G is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Suren G. Dutia is a corporate director associated with Citius Oncology, Inc. and Citius Pharmaceuticals, Inc. He has participated in several SEC filings related to his role but has not made any reported purchases or sales of stock in these companies.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-22 | CTOR | CITIUS ONCOLOGY, INC. | A — Grant or award | 300.0K | $0.00 | |
| 2025-12-01 | CTOR | CITIUS ONCOLOGY, INC. | A — Grant or award | 300.0K | $0.00 | |
| 2025-09-19 | CTOR | CITIUS ONCOLOGY, INC. | A — Grant or award | 300.0K | $0.00 |
Suren G. Dutia is a corporate director associated with Citius Oncology, Inc. and Citius Pharmaceuticals, Inc. He has participated in several SEC filings related to his role but has not made any reported purchases or sales of stock in these companies.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Dutia Suren G profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.